Jang SJ - Search Results

1

Comparison of genetic and epigenetic alterations at 11 tumor suppressor loci in pulmonary sclerosing hemangioma and adenocarcinoma.

Lee HJ, Jang SJ, Chun SM, Park SI, Kim DK, Choi J. Lee HJ, et al. Among authors: jang sj. Exp Lung Res. 2011 Aug;37(6):344-53. doi: 10.3109/01902148.2011.577267. Epub 2011 Jun 7. Exp Lung Res. 2011. PMID: 21649526 Free article.

2

Lymphocytic gastritis in Helicobacter pylori-positive gastric MALT lymphoma--report of two cases.

Song DE, Kim JS, Huh JR, Choi J, Jang SJ, Yu E. Song DE, et al. Among authors: jang sj. Korean J Gastroenterol. 2005 May;45(5):354-60. Korean J Gastroenterol. 2005. PMID: 15908769

3

Overexpression of the wip1 gene abrogates the p38 MAPK/p53/Wip1 pathway and silences p16 expression in human breast cancers.

Yu E, Ahn YS, Jang SJ, Kim MJ, Yoon HS, Gong G, Choi J. Yu E, et al. Among authors: jang sj. Breast Cancer Res Treat. 2007 Mar;101(3):269-78. doi: 10.1007/s10549-006-9304-y. Epub 2006 Aug 9. Breast Cancer Res Treat. 2007. PMID: 16897432

4

The estrogen receptor alpha pathway induces oncogenic Wip1 phosphatase gene expression.

Han HS, Yu E, Song JY, Park JY, Jang SJ, Choi J. Han HS, et al. Among authors: jang sj. Mol Cancer Res. 2009 May;7(5):713-23. doi: 10.1158/1541-7786.MCR-08-0247. Epub 2009 May 12. Mol Cancer Res. 2009. PMID: 19435816

5

A novel histone deacetylase inhibitor, CG0006, induces cell death through both extrinsic and intrinsic apoptotic pathways.

Hwang JJ, Kim YS, Kim MJ, Jang S, Lee JH, Choi J, Ro S, Hyun YL, Lee JS, Kim CS. Hwang JJ, et al. Anticancer Drugs. 2009 Oct;20(9):815-21. doi: 10.1097/CAD.0b013e3283300a0f. Anticancer Drugs. 2009. PMID: 19644355

6

Diagnostic utility of EWS break-apart fluorescence in situ hybridization in distinguishing between non-cutaneous melanoma and clear cell sarcoma.

Song JS, Choi J, Kim JH, Jang SJ, Cho KJ. Song JS, et al. Among authors: jang sj. Pathol Int. 2010 Sep;60(9):608-13. doi: 10.1111/j.1440-1827.2010.02570.x. Pathol Int. 2010. PMID: 20712646

7

CG0006, a novel histone deacetylase inhibitor, induces breast cancer cell death via histone-acetylation and chaperone-disrupting pathways independent of ER status.

Kim HM, Kim CS, Lee JH, Jang SJ, Hwang JJ, Ro S, Hyun YL, Choi J. Kim HM, et al. Among authors: jang sj. Breast Cancer Res Treat. 2011 Nov;130(2):365-75. doi: 10.1007/s10549-010-1310-4. Epub 2010 Dec 24. Breast Cancer Res Treat. 2011. PMID: 21184271

8

Deregulated expression of microRNA-221 with the potential for prognostic biomarkers in surgically resected hepatocellular carcinoma.

Yoon SO, Chun SM, Han EH, Choi J, Jang SJ, Koh SA, Hwang S, Yu E. Yoon SO, et al. Among authors: jang sj. Hum Pathol. 2011 Oct;42(10):1391-400. doi: 10.1016/j.humpath.2010.12.010. Epub 2011 Apr 1. Hum Pathol. 2011. PMID: 21458843

9

A novel histone deacetylase inhibitor, CG200745, potentiates anticancer effect of docetaxel in prostate cancer via decreasing Mcl-1 and Bcl-XL.

Hwang JJ, Kim YS, Kim T, Kim MJ, Jeong IG, Lee JH, Choi J, Jang S, Ro S, Kim CS. Hwang JJ, et al. Invest New Drugs. 2012 Aug;30(4):1434-42. doi: 10.1007/s10637-011-9718-1. Epub 2011 Jul 20. Invest New Drugs. 2012. PMID: 21773733

10

Clinicopathologic implication of ALK rearrangement in surgically resected lung cancer: a proposal of diagnostic algorithm for ALK-rearranged adenocarcinoma.

Paik JH, Choi CM, Kim H, Jang SJ, Choe G, Kim DK, Kim HJ, Yoon H, Lee CT, Jheon S, Choe JY, Chung JH. Paik JH, et al. Among authors: jang sj. Lung Cancer. 2012 Jun;76(3):403-9. doi: 10.1016/j.lungcan.2011.11.008. Epub 2011 Nov 30. Lung Cancer. 2012. PMID: 22129856

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

854 results

Search Page

Filters